Pesquisas alternativas:
renal compare » penal compare (Expandir a Pesquisa), rectal compared (Expandir a Pesquisa), rural compared (Expandir a Pesquisa)
aid company » grid company (Expandir a Pesquisa), land company (Expandir a Pesquisa), rfid company (Expandir a Pesquisa)
company car » company case (Expandir a Pesquisa), company a (Expandir a Pesquisa), company carlos (Expandir a Pesquisa)
nat compr » la compr (Expandir a Pesquisa)
compr can » comp can (Expandir a Pesquisa), computer can (Expandir a Pesquisa), compared can (Expandir a Pesquisa)
can non » dan non (Expandir a Pesquisa), than non (Expandir a Pesquisa)
car new » care new (Expandir a Pesquisa), cara new (Expandir a Pesquisa), cars new (Expandir a Pesquisa)
j nat » j nart (Expandir a Pesquisa), _ nat (Expandir a Pesquisa), e nat (Expandir a Pesquisa)
a aid » a aids (Expandir a Pesquisa), a aiad (Expandir a Pesquisa), a aida (Expandir a Pesquisa)
renal compare » penal compare (Expandir a Pesquisa), rectal compared (Expandir a Pesquisa), rural compared (Expandir a Pesquisa)
aid company » grid company (Expandir a Pesquisa), land company (Expandir a Pesquisa), rfid company (Expandir a Pesquisa)
company car » company case (Expandir a Pesquisa), company a (Expandir a Pesquisa), company carlos (Expandir a Pesquisa)
nat compr » la compr (Expandir a Pesquisa)
compr can » comp can (Expandir a Pesquisa), computer can (Expandir a Pesquisa), compared can (Expandir a Pesquisa)
can non » dan non (Expandir a Pesquisa), than non (Expandir a Pesquisa)
car new » care new (Expandir a Pesquisa), cara new (Expandir a Pesquisa), cars new (Expandir a Pesquisa)
j nat » j nart (Expandir a Pesquisa), _ nat (Expandir a Pesquisa), e nat (Expandir a Pesquisa)
a aid » a aids (Expandir a Pesquisa), a aiad (Expandir a Pesquisa), a aida (Expandir a Pesquisa)
1
“...Agent-based modeling by a bottom-up approach has shown that it has enough capacity to provide a...”
Obter o texto integral
Obter o texto integral
Online
2
3
Por Masyuk, Tatyana V, Radtke, Brynn N, Stroope, Angela J, Banales, Jesús M, Gradilone, Sergio A, Huang, Bing, Masyuk, Anatoliy I, Hogan, Marie C, Torres, Vicente E, LaRusso, Nicholas F
Publicado em 2013
“...) with Octreotide (OCT; a somatostatin analogue that preferentially binds to SSTR2), inhibits cyst growth. We now...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Campero, José M., Ramos, Christián G., Valdevenito, Raúl, Mercado, Alejandro, Fullá, Juan
Publicado em 2012
“.... RESULTS: The indication for LPN was a renal tumor or a complex renal cyst in the 96% of the cases. A...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Afzali, Behdad, Edozie, Francis C., Fazekasova, Henrieta, Scottà, Cristiano, Mitchell, Peter J., Canavan, James B., Kordasti, Shahram Y., Chana, Prabhjoat S., Ellis, Richard, Lord, Graham M., John, Susan, Hilton, Rachel, Lechler, Robert I., Lombardi, Giovanna
Publicado em 2013
“... T cells to induce transplant tolerance is now technically feasible. However, regulatory T cells from...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Jones, A. D., Waduud, M. A., Walker, P., Stocken, D., Bailey, M. A., Scott, D. J. A.
Publicado no BJS Open (2019)
“... prospective non‐randomized trial. The pooled early postoperative mortality rate following FEVAR was 3·3 (95...”Publicado no BJS Open (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por van Essen, Martijn, Krenning, Eric P., Kam, Boen L., de Herder, Wouter W., van Aken, Maarten O., Kwekkeboom, Dik J.
Publicado em 2008
“... capecitabine to (177)Lu-octreotate, as a radio-sensitiser, may enhance these anti-tumour effects. We now...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Mues, Katherine E, Liede, Alexander, Liu, Jiannong, Wetmore, James B, Zaha, Rebecca, Bradbury, Brian D, Collins, Allan J, Gilbertson, David T
Publicado no Clin Epidemiol (2017)
“..., select individuals with disabilities aged <65 years, and individuals with end-stage renal disease...”Publicado no Clin Epidemiol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Bashir, Mohamad, Field, Mark, Shaw, Matthew, Fok, Matthew, Harrington, Deborah, Kuduvalli, Manoj, Oo, Aung
Publicado no Aorta (Stamford) (2014)
“... with survival: renal dysfunction [hazard ratio (HR) = 3.11; 95% confidence interval (CI) = 1.44-6.73], New York...”Publicado no Aorta (Stamford) (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por S. V. Popov, R. G. Guseynov, I. N. Orlov, O. N. Skryabin, A. V. Davydov, R. S. Barkhitdinov, A. S. Katunin, M/ M. Mirzabekov
Publicado em 2019-06-01
“...Background. Restoring the quality of life of patients to a level comparable to that of practically...”Publicado em 2019-06-01
Obter o texto integral
Artigo
11
Por Jaskowski, Troy D., Martins, Thomas B., Litwin, Christine M., Hill, Harry R.
Publicado no J Clin Lab Anal (2002)
“...Goodpasture syndrome is a life‐threatening autoimmune kidney and pulmonary disease...”Publicado no J Clin Lab Anal (2002)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... was measured at baseline and at the conclusion of each study. A value between 3.4 mg/mmol and below 33.9 mg...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
PP50. STEREOTACTIC RADIOSURGERY AS PALLIATION FOR CEREBRAL METASTASES – A TERTIARY CENTRE EXPERIENCE
“... with oligometastatic disease, SRS can be a good alternative to Whole Brain Radiotherapy (WBRT) for palliation. Our...”Obter o texto integral
Obter o texto integral
Artigo
14
Publicado no Lancet
(2019)
“... people. We undertook a meta-analysis of data from all large statin trials to compare the effects...”Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Amaral, Luciana Silva do, Quintas, Luis Eduardo Menezes, Noël, François Germain, Universidade Federal do Rio de Janeiro.
Publicado em 2011
“... higher IC50 (3.4 ± 0.2 μM). Tests for evaluating phospho-ERK1/2 in LLC-PK1 cells (porcine proximal renal...”Publicado em 2011
Obter o texto integral
Livro
16
Publicado em 2010
“... of the patient. CTA is licensed by Health Canada as a Class III device. Currently, two companies have licenses...”Obter o texto integral
Obter o texto integral
Artigo
17
Por Kovacs, G.
Publicado em 1989
“...Most renal cell carcinomas are characterized by constant loss of the 3p13-pter chromosome segment...”Publicado em 1989
Obter o texto integral
Obter o texto integral
Artigo
18
Por Jha, P. K., Bansal, S. B., Sethi, S. K., Jain, M., Sharma, R., Nandwani, A., Phanish, M. K., Duggal, R., Tiwari, A. K., Ghosh, P., Ahlawat, R., Kher, V.
Publicado no Indian J Nephrol (2016)
“... transplantation. With the advent of effective preconditioning protocols, it is now possible to do renal...”Publicado no Indian J Nephrol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“...1 The effect of intra-aortic administration (i.a.) of prostaglandin E2 (PGE2) on renal blood flow...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“... demonstrated a tolerable side effect profile and is currently being compared with sunitinib in a Phase III...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo